Latest filing published 10 Sept 2026 for Jazz Pharmaceuticals plc, €295k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mary Elizabeth Henderson appears in our data through filings on Jazz Pharmaceuticals plc shares, published by SEC (Form 4). The record holds 14 filings, for trades running from 11 August 2023 to 8 September 2026.
Every open-market trade on record is a sale: 3 sales worth €1.3M. Besides market trades, the filings include 9 share grants. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 10 September 2026, the filings show a share grant worth €295k in Jazz Pharmaceuticals plc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations